Concepedia

Sarah J. Haycock-Lewandowski

SJ

Statistics

Publications

4

Citations

203

H-Index

4

Active since

2005

Affiliations

Pfizer (United Kingdom)(Current)

Sarah J. Haycock-Lewandowski is an author at Pfizer (United Kingdom) specializing in drug discovery, pharmacy, and pharmacology.

Publications per year

2005–2008

4

Publications

4

Development of a Bulk Enabling Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist

Sarah J. Haycock-Lewandowski, Alexander Wilder, Jens Åhman · Organic Process Research & Development · 2008 · 93 citations

, , +16

Initial synthesis of UK-427,857 (Maraviroc)

David A. Price, Simon Gayton, Matthew D. Selby et al. · Tetrahedron Letters · 2005 · 51 citations

, , +5

Process Research and Scale-up of a Commercialisable Route to Maraviroc (UK-427,857), a CCR-5 Receptor Antagonist

Jens Åhman, Melissa Birch, Sarah J. Haycock-Lewandowski et al. · Organic Process Research & Development · 2008 · 42 citations

, , +14

A Practical Synthesis of Piperidine-/Tropane-Substituted 1,2,4-Triazoles

David A. Price, Simon Gayton, Matthew D. Selby et al. · Synlett · 2005 · 17 citations

, , +15

1–4 of 4